Cholesterol policy and the primary prevention of coronary disease: Reflections on clinical and population strategies

Annual Review of Nutrition

Volumn 16, Issue , 1996, Pages 349-382

  Naylor, C David ^a,b   Paterson, J Michael ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

cholesterol; clinical guidelines; coronary heart disease; dyslipidemias; population based; primary prevention

Indexed keywords

CHOLESTEROL; FIBRIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET THERAPY; DYSLIPIDEMIA; HEALTH CARE POLICY; HUMAN; LOW FAT DIET; MASS SCREENING; META ANALYSIS; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW;

EID: 0029848490     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nu.16.070196.002025     Document Type: Review

References (189)

1. American Academy of Pediatrics, Committee on Nutrition. 1992. Statement on Cholesterol. Pediatrics 90:469-73
2. Arntzenius AC, Kromhout D, Barth JD, Reiber JH, Bruschke AV, et al. 1985. Diet, lipoproteins and the progression of coronary atherosclerosis: The Leiden Intervention Trial. N. Engl. J. Med. 312: 805-11
3. Assmann G, Schulte H. 1994. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 110(Suppl.):S11-21
4. Avis NE, Smith KW, McKinlay JB. 1989. Accuracy of perceptions of heart attack risk: what influences perceptions and can they be changed? Am. J. Publ. Health 79(12):1608-12
5. Bandura A. 1977. Social Learning Theory. Englewood Cliffs, NJ: Prentice-Hall
6. Baron JA, Gleason R, Crowe B, Mann JI. 1990. Preliminary trial of the effect of general practice based nutritional advice. Br. J. Gen. Pract. 40:137-41
7. Barratt A, Reznik R, Irwig L, Cuff A, Simpson JM, et al. 1994. Worksite cholesterol screening and dietary intervention: The Staff Healthy Heart Project. Am. J. Publ. Health 84:779-82
8. Betteridge DJ, Dodson PM, Durrington PN, Hughes EA, Laker MF, et al. 1993. Management of hyperlipidemia: guidelines of the British Hyperlipidaemia Association. Postgrad. Med. J. 69:359-69
9. Black JS, Sefcik T, Kapoor W. 1990. Health promotion and disease prevention in the elderly. Arch. Intern. Med. 150:389-93
10. Bobbio M, Demichelis B, Giustetto. 1994. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet 343:1209-11
11. Breidenstein BC. 1988. Changes in consumer attitudes toward red meat and their effects on marketing strategies. Food Technol. January: 112-16
12. British Cardiac Society Working Group on Coronary Prevention. 1987. Conclusions and recommendations. Br. Heart J. 57:188-89
13. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin J, et al. 1990. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med. 323(19): 1289-98
14. Browner WS. 1986. Estimating the impact of risk factor modification programs. Am. J. Epidemiol. 123:143-53
15. Browner W, Baron R, Sokowitz S, Adler L, Gullian D. 1992. Physician management of hypercholesterolemia: randomized trial of continuing medical education. Clin. Res. 40:577A (Abstr.)
16. Bruno R, Arnold C, Jacobson L, Winick M, Wynder E. 1983. Randomized controlled trial of a nonpharmacologic cholesterol reduction program at the worksite. Prev. Med. 12:523-32
17. Bucher HC, Weinbacher M, Gyr K. 1994. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. Br Med. J. 309:761-64
18. Buchwald H, Campos CT, Boen JR, Nguyen P, Williams SE. 1994. Disease-free interval assessments after partial ileal bypass in coronary heart disease patients. J. Am. Coll. Cardiol. 23:389A (Abstr.)
19. Cade J, Booth S. 1990. What can people eat to meet the dietary goals, and how much does it cost? J. Hum. Nutr. Diet 3:199-207
20. Campbell MK, DeVellis BM, Strecher VJ, Ammerman AS, DeVellis RF, Sandler RS. 1994. Improving dietary behavior: the effectiveness of tailored messages in primary care settings. Am. J. Publ. Health 84:783-87
21. Canadian Consensus Conference on Cholesterol. 1988. Final report. Can. Med. Assoc. J. 139(Suppl.):1-8
22. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemia. 1990. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Can. Med. Assoc. J 142: 1371-82
23. Canadian Task Force on the Periodic Health Examination. 1979. The periodic health examination. Can. Med. Assoc. J. 121:1193-254
24. Canadian Task Force on the Periodic Health Examination. 1993. Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Can. Med. Assoc. J. 148(4):521-38
25. Carleton RA, Lasater TM, Assaf AR, Feldman HA, McKinlay S, et al. 1995. The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Am. J. Publ. Health 85:777-85
26. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835-38
27. Charlson ME, Alderman M, Melcher L. 1982. Absenteeism and labelling in hypertensive subjects. Prevention of an adverse impact in those at high risk. JAMA 73:165-70
28. Cole-Hamilton I, Lang T. 1986. Tightening Belts. A Report on Poverty and Food. London: London Food Commission
29. Collins R, Keech A, Peto R, Sleight P, Kjekshus J, et al. 1992. Cholesterol and total mortality: need for larger trials. Br. Med. J. 304:1689
30. Communications/Implementation Committee (Health and Welfare Canada). 1990. Action Towards Healthy Eating: Canada's Guidelines for Healthy Eating and Recommended Strategies for Implementation. Ottawa: Minister of Supply and Services Canada
31. Consensus Panel. 1992. The management of hyperlipidaemia: a consensus statement. Med. J. Aust. 156(Suppl.): S1-16
32. Crawford DA, Baghurst KI. 1990. Diet and health: a national survey of beliefs, behaviors, and barriers to change in the community. Aust. J. Nutr. Diet 47:97-104
33. Crouch M, Sallis JF, Farquhar JW, Haskell WL, Ellsworth NM, et al. 1986. Personal and mediated health counselling for sustained dietary reduction of hypercholesterolemia. Prev. Med. 15: 282-91
34. Cucherat M, Boissel J-P. 1993. Meta-analysis of results from clinical trials on prevention of coronary heart disease by lipid-lowering interventions. Clin. Trials Meta-Anal. 28:109-29
35. Dales LG, Friedman GD, Ramcharan S, Siegelaub AB, Cambell BA, et al. 1973. Multiphasic checkup evaluation study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Prev. Med 2:221-35
36. Davey Smith G, Pekkanen J. 1992. Should there be a moratorium on the use of cholesterol lowering drugs? Br. Med. J. 304:431-34
37. Davey Smith G, Song F, Sheldon TA. 1993. Cholesterol lowering and mortality: the importance of considering initial level of risk. Br. Med. J. 306:1367-73
38. Davis CE, Rifkind BM, Brenner H, Gordon DJ. 1990. A single cholesterol measurement underestimates the risk of coronary heart disease. JAMA 264: 3044-46
39. Denke MA. 1994. Individual responsiveness to a cholesterol-lowering diet in post-menopausal women with moderate hypercholesterolemia. Arch. Intern. Med. 154(17):1977-82
40. Denke MA. 1995. Cholesterol-lowering diets. A review of the evidence. Arch. Intern. Med. 155:17-26
41. Denke MA, Grundy SM. 1994. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch. Intern. Med. 154 (3):317-25
42. Dennison BA, Jenkins PL, Pearson TA. 1994. Challenges to implementing the current pediatric cholesterol screening guidelines into practice. Pediatrics 94 (3):296-302
43. Diller PM, Huster GA, Leach AD, Laskarzewski PM, Sprecher DL. 1995. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. J. Pediatr. 126(3):345-52
44. Elder JP, McGraw SA, Abrams DB, Ferreira A, Lasater TM, et al. 1986. Organizational and community approaches to community-wide prevention of heart disease: the first two years of the Pawtucket Heart Health Program. Prev. Med. 15:107-17
45. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 1988. Report of the National Cholesterol Education Program. Arch. Intern. Med. 148:36-69
46. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 1993. Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 269(23):3015-23
47. Expert Panel on Population Strategies for Blood Cholesterol Reduction. 1991. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 83(6):2154-232
48. Family Heart Study Group. 1994. Randomized controlled trial evaluating cardiovascular screening and intervention in general practice: principle results of British family heart study. Br. Med. J. 308:313-20
49. Farquhar JW, Fortmann SP, Flora JA, Taylor B, Haskell WL, et al. 1990. Effects of community wide education on cardiovascular risk factors: The Stanford Five-City Project. JAMA 264(3): 359-65
50. Farquhar JW, Fortmann SP, Maccoby N, Haskell WL, Williams PT, et al. 1985. The Stanford Five-City Project: design and methods. Am. J. Epidemiol. 122:323-34
51. Farquhar JW, Maccoby N, Wood PD, Alexander JK, Breitrose H, et al. 1977. Community education for cardiovasular health. Lancet 1:1192-95
52. Farrow L, Taylor WC, Arnold RM. 1992. Absolutely relative: how research results are summarized can affect treatment decisions. Am. J. Med 29:121-24
53. Feldman W. 1990. Routine cholesterol surveillance in childhood. Pediatrics 86: 150 (Letter)
54. Flay BR, DiTecco D, Schlegel RP. 1980. Mass media in health promotion: an analysis using extended information-processing model. Health Educ. Q. 7: 127-47
55. Frank E, Winkleby MA, Fortemann SP, Rockhill B, Farquhar JW. 1992. Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. JAMA 268(12):1566-72
56. Gemson DH, Elinson J. 1986. Prevention in primary care: variability in physician practice patterns in New York City. Am. J. Prev. Med. 2:226-34
57. Giles WH, Anda RF, Jones DH, Serdula MK, Merritt RK, DeStafano F. 1993. Recent trends in the identification and treatment of high blood cholesterol by physicians: progress and missed opportunities. JAMA 269:1133-38
58. Glanz K, Mullis R. 1988. Environmental interventions to promote healthy eating: a review of models, programs, and evidence. Health Educ. Q. 15:395-415
59. Glanz K, Seewald-Klein T. 1986. Nutrition at the worksite: an overview. J. Nutr. Educ. 18(1):S1-12
60. Golier JA, Marzuk PM, Leon AC, Weiner C, Tardiff K. 1995. Low serum cholesterol level and attempted suicide. Am. J. Psychiatry 152(3):419-23
61. Goodman R, Steckler A, Hoover S, Schwartz R. 1993. A critique of contemporary community health promotion approaches: based on a qualitative review of six programs in Maine. Am. J. Health Promot. 7:208-21
62. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. 1995. Cholesterol reduction yields clinical benefit: a new look at old data. Circulation 91: 2274-82
63. Grimshaw JM, Russell IT. 1993. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342:1317-22
64. Grover SA, Coupal L, Hu X. 1995. Identifying adults at increased risk of coronary disease. How well do cholesterol guidelines work? JAMA 274 (10): 801-6
65. Grover SA, Lowensteyn I, Esrey KL, Steinert Y, Joseph L, Abrahamowicz M. 1995. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study. Br. Med. J. 310:975-78
66. Grover SA, Palmer CS, Coupal L. 1994. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort. Arch. Intern. Med. 154(6):679-84
67. Grundy SM, Bilheimer D, Blackburn H, Brown VW, Kwiterovich PO, et al. 1982. Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee. Circulation 65:839-54A
68. Harris T, Havlik R, Ettinger WH. 1995. Cholesterol and coronary heart disease risk in elderly patients. JAMA 273(17): 1329 (Letter)
69. Havas S, Reisman J, Hsu L, Koumjian L. 1991. Does cholesterol screening result in negative labelling effects? Arch. Intern. Med. 51:115-35
70. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. 1978. Increased absenteeism from work after detection and labelling of hypertensive patients. N. Engl. J. Med. 299:741-44
71. Headrick LA, Speroff T, Pelecanos HI, Cebul RD. 1992. Efforts to improve compliance with the National Cholesterol Education Program guidelines. Results of a randomized controlled trial. Arch. Intern. Med. 152:2490-96
72. Hegsted DM, Augman LM, Johnson JA, Dallal GE. 1993. Dietary fat and serum lipids: an evaluation of experimental data. Am. J. Clin. Nutr. 57:875-83
73. Hellenius ML, Dahlof C, Aberg H, Krakau I, de Faire U. 1995. Quality of life is not negatively affected by diet and exercise intervention in healthy men with cardiovascular risk factors. Qual. Life Res. 4(1):13-20
74. Hjermann I, Holme I, Velve Byre K, Leren P. 1981. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 2:1303-10
75. Holme I. 1990. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 82:1916-24
76. Hulley SB, Newman TB. 1992. Position statement: cholesterol screening in children is not indicated, even with positive family history. J. Am. Coll. Nutr. 11(S): 20-22S
77. Hulley SB, Newman TB. 1994. Cholesterol in the elderly: is it important? JAMA 272(17):1372-74
78. Hulley SB, Newman TB, Grady D, Garber AM, Baron RB, Browner WS. 1993. Should we be measuring blood cholesterol levels in young adults? JAMA 269: 1416-19
79. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, et al. 1993. The efficacy of intensive dietary therapy alone or combined with Lovastatin in outpatients with hypercholesterolemia. N. Engl. J. Med 328: 1213-19
80. Hux JE, Naylor CD. 1995. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment? Med Decis. Making 15:152-57
81. Imperial Cancer Research Fund OXCHECK Study Group. 1995. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Br. Med. J. 310: 1099-104
82. International Task Force for the Prevention of Coronary Heart Disease, European Atherosclerosis Society. 1992. Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr. Metab. Cardiovasc. Dis. 2:113-56
83. Inter-Society Commission for Heart Disease Resources. 1970. Primary prevention of the atherosclerotic diseases. Circulation 42:A55-98
84. Irish Hyperlipidaemia Association. 1992. Guidelines for the Management of Hyperlipidaemia. Dublin: Irish Hyperlipidaemia Assoc. 3rd ed.
85. Irvine J, Logan AG. 1994. Is knowing your cholesterol number harmful? J. Clin. Epidemiol. 47(2):131-45
86. Jacobs DR, Blackburn H. 1993. Models of effects of low blood cholesterol on the public health: implications for practice and policy. Circulation 87(3):1033-36
87. Jacobs DR, Muldoon MF, Rastam L. 1995. Invited commentary: low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: a search for causes and confounders. Am. J. Epidemiol. 141(6):518-22
88. Johnston JM, Jansen GR, Anderson J, Kendall P. 1994. Comparison of group diet instruction to a self-directed program for cholesterol reduction. J. Nutr. Educ. 26:140-45
89. Katz DL. 1995. Cholesterol and coronary heart disease risk in elderly patients. JAMA 273(17):1329-30 (Letter)
90. Keys A, Anderson JT, Grande F. 1959. Serum cholesterol in man: diet fat and intrinsic responsiveness. Circulation 19: 201-14
91. Kinosian B, Glick H, Garland G. 1994. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann. Intern. Med 121:641-47
92. Krishnaswami S, Jose VJ, Joseph G. 1994. Lack of correlation between coronary risk factors and CAD severity. Int. J. Cardiol. 47(1):37-43
93. Kronmal RA, Cain KC, Ye Z, Omenn GS. 1993. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch. Intern. Med. 153:1065-73
94. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, et al. 1994. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 272:1335-40
95. Lauer RM, Clarke WR. 1990. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia. The Muscatine Study. JAMA 264:3034-38
96. Law MR, Thompson SG, Wald NJ. 1994. Assessing possible hazards of reducing serum cholesterol. Br. Med. J. 308:373-79
97. Law MR, Wald NJ, Thompson SG. 1994. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease? Br. Med. J. 308:367-73
98. Lefebvre CR, Peterson GS, McGraw SA, Lasater TM, Sennett L, et al. 1986. Community intervention to lower blood cholesterol: the "Know Your Cholesterol" campaign in Pawtucket, Rhode Island. Health Educ. Q. 13:117-29
99. Levin SJ, Ornstein SM. 1990. Management of hypercholesterolemia in a family practice setting. J. Fam. Pract. 31: 613-17
100. Light L, Portnoy B, Blair JE, Smith JM, Rodgers AB, et al. 1989. Nutrition education in supermarkets. Fam. Commun. Health 12(1):43-52
101. Lindholm LH, Ekbom T, Dash C, Eriksson M, Tibblin G, et al. 1995. The impact of health care advice given in primary care on cardiovasular risk. Br. Med. J. 310:1105-9
102. Llewellyn-Thomas HA, Paterson JM, Carter JA, Hardacre GD, Dunn EV, Naylor CD. 1994. Cholesterol-lowering medication in primary prevention: can physicians meet patients' "demands" of reduced coronary risk? Med. Decis. Making 14(4):436 (Abstr.)
103. Lloyd HM, Paisley CM, Mela DJ. 1995. Barriers to the adoption of reduced-fat diets in a UK population. J. Am. Diet. Assoc. 95:316-22
104. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. 1989. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N. Engl. J. Med. 321:1306-11
105. Luepker RV, Murray DM, Jacobs DR, Mittelmark MB, Bracht N, et al. 1994. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. Am. J. Publ. Health 84(9): 1383-93
106. MacLean DR. 1994. Theoretical rationale of community intervention for the prevention and control of cardiovascular disease. Health Rep. 6(1):174-79
107. MacMahon S. 1992. Lowering cholesterol: effects on trauma death, cancer death, and total mortality. Aust. NZ J. Med. 22(Suppl. 5):580-82
108. Madlon-Kay DJ. 1989. Improvement in family physician recognition and treatment of hypercholesterolemia. Arch. Intern. Med. 149:1754-55
109. Mancini GBJ. 1995. Mechanisms underlying reduction of clinical events in lipid lowering trials. Can. J. Cardiol. 11(Suppl. C):15-17C
110. Mann JI, Crooke M, Fear H. 1993. Guidelines for detection and management of dyslipidaemias. NZ Med. J. 106:133-41
111. Manson JE. 1994. Postmenopausal hormone replacement therapy and atherosclerotic disease. Am. Heart J. 128: 1337-43
112. McAllister M, Baghurst K, Record S. 1994. Financial costs of healthful eating: a comparison of three different approaches. J. Nutr. Educ. 26:131-39
113. McCann BS, Retzlaf BM, Dowdy AA, Walden CE, Knopp RH. 1990. Promoting adherence to low-fat, low-cholesterol diets: review and recommendations. J. Am. Diet. Assoc. 90:1408-14
114. McGee D. 1973. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Framingham Section 28. US Dep. Health Educ. Welfare Publ. No. (NIH) 74-618
115. McIsaac WJ, Naylor CD, Basinski A. 1991. Mismatch of coronary risk and treatment intensity under the National Cholesterol Education Program guidelines. J. Gen. Intern. Med. 6: 518-23
116. Milne BJ, Logan AG, Flanagan PT. 1985. Alteration in health perception and life-style in treated hypertensives. J. Chron. Dis. 38:37-45
117. Mittelmark MB, Hunt MK, Heath GW, Schmid TL. 1993. Realistic outcomes: lessons from community-based research and demonstration programs for the prevention of cardiovascular diseases. J. Publ. Health Policy 14(4):437-62
118. Mittelmark MB, Luepker RV, Jacobs DR, Bracht NF, Carlaw RW, et al. 1986. Community-wide prevention of cardiovascular disease: education strategies of the Minnesota Heart Health Program. Prev. Med. 15:1-17
119. Mooney C. 1990. Cost and availability of healthy food choices in a London health district. J. Hum. Nutr. Diet 3: 111-20
120. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL. 1993. Plasma cholesterol and depressive symptoms in older men. Lancet 341:75-79
121. Muldoon M, Manuck S, Mathews K. 1990. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br. Med. J. 301:309-14
122. Mullis RM, Hunt MK, Foster M, Hachfeld L, Lansing D, et al. 1987. The shop smart for your heart grocery program. J. Nutr. Educ. 19(5):225-28
123. Multiple Risk Factor Intervention Trial Research Group. 1982. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 248:1465-77
124. Murray TK, Rae JR. 1979. Nutrition recommendations for Canadians. Can. Med. Assoc. J. 120:1241-42
125. National Cholesterol Education Program. 1991. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. NIH Publ. No. 91-2732. Bethesda MD: US Dep. Health Hum. Serv., Public Health Serv.
126. National Diet-Heart Study Research Group. 1968. National Diet-Heart Study final report. Circulation 37(Suppl. 1): 11-428
127. Naylor CD, Basinski A, Frank JW, Rachlis MM. 1990. Asymptomatic hypercholesterolemia, a clinical policy review. J. Clin. Epidemiol. 43(10):1021-121
128. Naylor CD, Chen E, Strauss B. 1992. Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann. Intern. Med. 117:916-21
129. Neil HAW, Roe L, Godlee RJP, Moore JW, Clark GMG, et al. 1995. Randomized trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. Br. Med. J. 310:569-73
130. Nestle M. 1993. Food lobbies, the food pyramid, and U.S. nutrition policy. Int. J. Health Serv. 23(3):483-96
131. Newman TB, Browner WS, Hulley SB. 1990. The case against childhood cholesterol screening. JAMA 264(23):3039-43
132. Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, et al. 1995. Population awareness and control of hypertension and hypercholesterolemia. Arch. Intern. Med. 155:677-84
133. Niknian M, McKinlay SM, Rakowski W, Carleton RA. 1989. A comparison of perceived and objective CVD risk in a general population. Am. J. Publ. Health 79(12):1653-54
134. Nutbeam D, Smith C, Murphy S, Catford J. 1993. Maintaining evaluation designs in long term community based health promotion programmes: Heart-beat Wales case study. J. Epidemiol. Commun. Health 47:127-33
135. Nutrition Committee. 1993. Rationale of the diet-heart statement of the American Heart Association. Circulation 88 (6):3008-29
136. Oliver MF. 1981. Serum cholesterol - the knave of hearts and the joker. Lancet 2:1090-95
137. Oliver MF. 1984. Coronary risk factors: should we not forget about mass control? World Health Forum 5:5-8
138. Pearson TA. 1991. Guidelines for the detection and treatment of elevated serum cholesterol: Which is the baby and which is the bathwater? Ann. Intern. Med. 115(4):324-26
139. Pietinen P, Nissinen A, Vartiainen E, Tuomilehto A, Uusitalo U, et al. 1988. Dietary changes in the North Karelia Project. Prev. Med. 17:183-93
140. Polk BF, Harlan LC, Cooper SP, Stromer M, Ignatius J, et al. 1984. Disability days associated with detection and treatment in a hypertension control program. Am. J. Epidemiol. 119:44-53
141. Puska PP, Nissinen A, Tuomilehto J, Salonen JT, Koskela K, et al. 1985. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia Project. Annu. Rev. Publ. Health 6:147-93
142. Putnam JJ. 1991. Food consumption, 1970-90. Food Rev. 14(3):2-11
143. Pyorala K, Debacker G, Graham I, Poole-Wilson P, Wood D, et al. 1994. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society, and the European Society of Hypertension. Eur. Heart J. 15:1300-31
144. Ramsay LE, Yeo WW, Jackson PR. 1991. Dietary reduction of serum cholesterol concentration: time to think again? Br. Med. J. 303:953-57
145. Rastam L, Luepker RV, Pirie PL. 1988. Effect of screening and referral on follow-up and treatment of high blood cholesterol levels. Am. J. Prev. Med. 4:244-48
146. Ravnskov U. 1992. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. Br. Med J. 305:15-19
147. Ravnskov U. 1995. Quotation bias in reviews of the diet-heart idea. J. Clin. Epidemiol. 48(5):713-19
148. Reeves RS, Foreyt JP, Scott LW, Mitchell RE, Wohlleb J, Gotto AM. 1983. Effects of a low cholesterol eating plan on plasma lipids: results of a three-year community study. Am. J. Publ. Health 73:873-77
149. Resnicow K, Berenson G, Shea S, Srinivasan S, Strong W, Wynder EL. 1991. The case against "the case against childhood cholesterol screening." JAMA 265: 3003-5
150. Rogers LQ, Johnson KC, Arheart KL. 1993. Current physician screening and treatment of hypercholesterolemic patients. Am. J. Med. Sci 306(2):124-28
151. Rosenman RH. 1993. The questionable roles of the diet and serum cholesterol in the incidence of ischemic heart disease and its 20th century changes. Homeostasis 34:1-44
152. Rosser WW, Palmer WH. 1993. Dissemination of guidelines on cholesterol. Effect on patterns of practice of general practitioners and family physicians in Ontario. Can. Fam. Phys. 39:280-84
153. Salomaa V, Arstila M, Kaarsalo E, Ketonen M, Kuulasmaa K, et al. 1992. Trends in the incidence of and mortality from coronary heart disease in Finland, 1983-1988. Am. J. Epidemiol. 136(11): 1303-15
154. Salonen JT, Puska P, Kottke TE, Tuomilehto J, Nissinen A. 1983. Decline in mortality from coronary heart disease in Finland from 1969-1979. Br. Med. J. 286:1857-60
155. Scandanavian Simvastatin Survival Study Group. 1994. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandanavian simvastatin survival study. Lancet 344:383-89
156. Schucker B, Wittes JT, Santanello NC, Weber SJ, McGoldrick D, et al. 1991. Change in cholesterol awareness and action. Results from national physician and public surveys. Arch. Intern. Med. 151:666-73
157. Schwartz NE. 1989. The president's corner. NIN Rapport 4:3
158. Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, et al. 1993. Prevalence of high blood cholesterol among US adults. JAMA 269(23):3009-14
159. Shepherd J, Betteridge DJ, Durrington P, Laker M, Lewis B, et al. 1987. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association. Br. Med. J. 295:1245-46
160. 159a. Shepherd J, Cobbe SM, Ford I, Isle CG, Lorimer AR, Macfarlane PW, et al. 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Engl. J. Med. 333:1301-7
161. Silberberg JS. 1994. After the meta-analyses: a commentary on treatment of dyslipidemia in the primary prevention of coronary heart disease. Aust. NZ J. Med. 24:717-21
162. Singleton SP, Neale AV, Scott RO, Hess JW. 1988. Cholesterol reduction among volunteers in a health promotion project. Am. J. Health Promot. 2:5-12
163. South-East London Screening Study Group. 1977. A controlled trial of multiphasic screening in middle-age: results of the South-East London Screening Study. Int. J. Epidemiol. 6:357-63
164. Stamler J, Wentworlh D, Neaton JD. 1986. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA 256:2823-28
165. Stamos T, Rosenson RS. 1995. Cholesterol and coronary heart disease risk in elderly patients. JAMA 273(17):1330 (Letter)
166. Stampfer MJ, Colditz GA. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20:47-63
167. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. 1991. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325(6):373-81
168. Stanhope JM, Sampson VM, Prior IAM. 1981. The Tokelau Island migrant study: serum lipid concentrations in two environments. J Chron. Dis. 34:45-55
169. Statistics Canada. 1985. Family Food Expenditures in Canada, 1982. Ottawa: Minister of Supply and Services Canada
170. Statistics Canada. 1989. Family Food Expenditures in Canada, 1986. Ottawa: Minister of Supply and Services Canada
171. Stehbens WE. 1993. The quality of epidemiological data in coronary heart disease and atherosclerosis. J. Clin. Epidemiol. 46(12):1337-46
172. Stern MP, Farquhar JW, Maccoby N, Russell SH. 1976. Results of a two-year health education campaign on dietary behavior. Circulation 54:826-33
173. Study Group of the European Atherosclerosis Society. 1988. The recognition and management of hyperlipidemia in adults: a policy statement of the European Atherosclerosis Society. Eur. Heart J. 9:571-600
174. Surgeon-General's Report on Nutrition and Health, Publ. No. 88-50210. 1988. Washington, DC: Dep. Health Hum. Serv.
175. Tannenbaum TN, Sampalis JS, Battista RN, Rosenberg ER, Joseph L. 1990. Early detection and treatment of hyperlipidemia: physician practices in Canada. Can. Med. Assoc. J. 143(9):875-81
176. Taylor CB, Fortmann SP, Flora J, Kayman S, Barrett DC, et al. 1991. Effect of long-term community health education on body mass index. Am. J. Epidemiol. 134:235-49
177. Tell GS, Evans GW, Folsom AR, Shimakawa T, Carpenter MA, Heiss G. 1994. Dietary fat intake and carotid wall thickness: the Atherosclerotic Risk in Communities (ARIC) Study. Am. J. Epidemiol. 139(10):979-89
178. Trichopoulou A, ed. 1990. Recommended dietary intakes in the EEC: scientific evidence and public health considerations. A workshop. Eur. J. Clin. Nutr. 44(Suppl. 2):1-125
179. Truswell AS. 1994. Review of dietary intervention studies: effect on coronary events and on total mortality. Aust. NZ J. Med. 24:98-106
180. US Department of Agriculture, Human Nutrition Information Service. 1985. Nationwide Food Consumption Survey Continuing Survey of Food Intakes by Individuals: Women 19-50 Years and Their Children 1-5 Years. NFCS, CSFII Rep. No. 85-1. Hyattsville, MD: US Dep. Agric.
181. US Department of Agriculture, Human Nutrition Information Service. 1985. Nationwide Food Consumption Survey Continuing Survey of Food Intakes by Individuals: Men 19-50 Years. NFCS, CSFII Rep. No. 85-3. Hyattsville, MD: US Dep. Agric.
182. US Senate Select Committee on Nutrition and Human Needs. 1977. Dietary Goals for the United States. Cambridge: MIT Press
183. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. 1994. Twenty-year trends in coronary risk factors in North Karelia and in other areas of Finland. Int. J. Epidemiol. 23: 495-504
184. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, et al. 1995. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274(2):131-36
185. Wagner EH, Strogatz DS. 1984. Hypertension labelling and well-being. Alternative explanations in cross-sectional data. J. Chron. Dis. 37:943-47
186. Weinstein ND. 1983. Reducing unrealistic optimism about illness susceptibility. Health Psychol. 2(1):11-20
187. Wilhelmensen L, Berglund G, Elmfeld D, et al. 1986. The multifactor primary prevention trial in Goteborg, Sweden. Eur. Heart J. 7:279-88
188. Wilson MG. 1991. Cholesterol reduction in the workplace and in community settings. J. Commun. Health 16(1):49-65
189. Witschi JC, Singer M, Wu-Lee M, Stare FJ. 1978. Family cooperation and effectiveness in a cholesterol-lowering diet. J. Am. Diet. Assoc. 72:284-88